Drug:
Reaction: DRUG DOSE OMISSION BY DEVICE
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26518649 |
US |
49 | |
Wheezing, Wrong technique in product usage process, Drug dose omission by device, Device breakage, |
||||
LEVALBUTEROL TARTRATE, RIVAROXABAN, BUDESONIDE, GABAPENTIN, |
||||
| 102 | 26518659 |
US |
79 | |
Dyspnoea, Drug dose omission by device, Off label use, Device delivery system issue, |
||||
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, HYDROXYCHLOROQUINE, ROSUVASTATIN, |
||||
| 103 | 26518677 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 104 | 26519816 |
CO |
1 | |
Drug dose omission by device, Device issue, |
||||
SOMATROPIN, |
||||
| 105 | 26519823 |
US |
13 | 2 |
Drug dose omission by device, Device information output issue, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 106 | 26519839 |
GB |
76 | 1 |
Drug dose omission by device, Device physical property issue, |
||||
SOMATROPIN, |
||||
| 107 | 26520485 |
US |
||
Drug dose omission by device, Device information output issue, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 108 | 26513031 |
US |
67 | 2 |
Pyrexia, Blister, Pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 109 | 26513670 |
US |
2 | |
Dyspnoea, Intentional product misuse, Device malfunction, Wrong technique in product usage process, Drug dose omission by device, Device use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 110 | 26514083 |
US |
59 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Off label use, |
||||
ALBUTEROL SULFATE, |
||||
| 111 | 26514305 |
US |
1 | |
Wrong technique in product usage process, Drug dose omission by device, Device malfunction, Product quality issue, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 112 | 26514963 |
CO |
11 | 1 |
Device information output issue, Device leakage, Product communication issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 113 | 26515892 |
US |
43 | 2 |
Haematochezia, Hidradenitis, Pain, Erythema, Pruritus, Condition aggravated, Crying, Device leakage, Drug dose omission by device, Device malfunction, |
||||
SECUKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 114 | 26515957 |
US |
||
Injection site reaction, Injection site pain, Device malfunction, Abnormal loss of weight, Drug dose omission by device, |
||||
FREMANEZUMAB-VFRM, |
||||
| 115 | 26516447 |
GB |
7 | 2 |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 116 | 26516451 |
CO |
1 | |
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 117 | 26516454 |
GB |
53 | 2 |
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 118 | 26516455 |
CO |
16 | 1 |
Drug dose omission by device, Off label use, Device power source issue, Device information output issue, Device issue, Device mechanical issue, Device malfunction, Device breakage, Device deployment issue, Device physical property issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 119 | 26516461 |
CO |
1 | |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 120 | 26516475 |
CO |
1 | |
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 121 | 26516563 |
CL |
72 | 2 |
Blood glucose increased, Device defective, Drug dose omission by device, |
||||
INSULIN DEGLUDEC, |
||||
| 122 | 26507718 |
US |
72 | 1 |
Nephrolithiasis, Sepsis, Device difficult to use, Drug dose omission by device, |
||||
EVOLOCUMAB, |
||||
| 123 | 26507838 |
US |
48 | 2 |
Injection site pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 124 | 26508100 |
US |
72 | 2 |
Headache, Injection site bruising, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 125 | 26508315 |
US |
52 | 2 |
Drug dose omission by device, Accidental exposure to product, Device difficult to use, Migraine, |
||||
ERENUMAB-AOOE, |
||||
| 126 | 26508872 |
US |
2 | |
Drug effect less than expected, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 127 | 26508875 |
US |
||
Drug dose omission by device, Incorrect dose administered by device, Device mechanical issue, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 128 | 26509084 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 129 | 26509280 |
US |
||
Drug dose omission by device, Device delivery system issue, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 130 | 26510746 |
US |
16 | 1 |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 131 | 26511022 |
US |
||
Drug dose omission by device, Device malfunction, Product knowledge deficit, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 132 | 26511318 |
US |
47 | 2 |
Drug dose omission by device, Product adhesion issue, |
||||
ESTRADIOL, |
||||
| 133 | 26511663 |
US |
2 | |
Device malfunction, Drug dose omission by device, Device leakage, Accidental exposure to product, |
||||
SECUKINUMAB, |
||||
| 134 | 26511758 |
CO |
1 | |
Drug dose omission by device, Device information output issue, Device use issue, |
||||
SOMATROPIN, |
||||
| 135 | 26511760 |
US |
19 | 2 |
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 136 | 26511763 |
KR |
11 | 1 |
Drug dose omission by device, Device use error, Poor quality device used, Device breakage, Device material issue, |
||||
SOMATROPIN, |
||||
| 137 | 26511766 |
CO |
2 | |
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, SOMATROPIN, SOMATROPIN, |
||||
| 138 | 26511783 |
CO |
1 | |
Incorrect dose administered by device, Drug dose omission by device, Device delivery system issue, |
||||
SOMATROPIN, |
||||
| 139 | 26511887 |
US |
4 | 1 |
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 140 | 26511894 |
US |
16 | 1 |
Drug dose omission by device, Device material issue, |
||||
SOMATROPIN, |
||||
| 141 | 26512036 |
US |
24 | 2 |
Injection site pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 142 | 26503167 |
US |
2 | |
Wrong technique in device usage process, Product storage error, Device issue, Device malfunction, Drug dose omission by device, |
||||
OFATUMUMAB, |
||||
| 143 | 26503197 |
US |
18 | 2 |
Headache, Device difficult to use, Drug dose omission by device, Accidental exposure to product, |
||||
ERENUMAB-AOOE, |
||||
| 144 | 26503231 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, Device defective, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 145 | 26503837 |
US |
12 | |
Asthma, Wheezing, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 146 | 26503861 |
US |
78 | |
Dyspnoea, Drug dose omission by device, Off label use, Device occlusion, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 147 | 26503891 |
US |
80 | |
Asthma, Adverse event, Drug dose omission by device, Device delivery system issue, Device deposit issue, |
||||
ALBUTEROL SULFATE, |
||||
| 148 | 26504168 |
US |
39 | |
Drug dose omission by device, Product use issue, Device defective, |
||||
ADALIMUMAB-AQVH, |
||||
| 149 | 26504169 |
US |
63 | 2 |
Drug dose omission by device, Device issue, No adverse event, |
||||
LIRAGLUTIDE, LOSARTAN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, BUPROPION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 150 | 26504399 |
US |
78 | 2 |
Cataract, Drug dose omission by device, |
||||
TERIPARATIDE, |
||||
| 151 | 26504832 |
US |
76 | 2 |
Device difficult to use, Migraine, Device use error, Drug dose omission by device, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, |
||||
| 152 | 26505653 |
US |
21 | 2 |
Injection site pain, Drug dose omission by device, Device delivery system issue, |
||||
FREMANEZUMAB-VFRM, |
||||
| 153 | 26505735 |
US |
14 | 1 |
Drug dose omission by device, Device breakage, Device mechanical issue, Device leakage, |
||||
SOMATROPIN, |
||||
| 154 | 26505744 |
CO |
1 | |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 155 | 26505745 |
US |
50 | 2 |
Drug dose omission by device, Device information output issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 156 | 26505750 |
US |
16 | 1 |
Drug dose omission by device, Device issue, |
||||
SOMATROPIN, |
||||
| 157 | 26505753 |
CO |
2 | |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 158 | 26505756 |
CO |
1 | |
Drug dose omission by device, Device breakage, Device material issue, |
||||
SOMATROPIN, |
||||
| 159 | 26505760 |
GB |
11 | 2 |
Device breakage, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 160 | 26505765 |
AR |
10 | 2 |
Device use error, Device breakage, Drug dose omission by device, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 161 | 26505770 |
US |
||
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 162 | 26505898 |
US |
||
Drug dose omission by device, Device delivery system issue, Product outer packaging issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 163 | 26506873 |
US |
20 | 2 |
Device issue, Needle issue, Accidental exposure to product, Drug dose omission by device, |
||||
SECUKINUMAB, |
||||
| 164 | 26506892 |
2 | ||
Drug dose omission by device, Device operational issue, Device power source issue, |
||||
INTERFERON BETA-1B, |
||||
| 165 | 26507222 |
US |
11 | 2 |
Device mechanical issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 166 | 26507227 |
CO |
||
Drug dose omission by device, Device defective, |
||||
SOMATROPIN, |
||||
| 167 | 26507229 |
US |
14 | 1 |
Drug dose omission by device, Device breakage, Device physical property issue, Device issue, |
||||
SOMATROPIN, |
||||
| 168 | 26507359 |
US |
||
Drug dose omission by device, No adverse event, |
||||
GLUCAGON, |
||||
| 169 | 26498564 |
US |
42 | |
Drug dose omission by device, Device delivery system issue, Device defective, No adverse event, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, |
||||
| 170 | 26499254 |
US |
||
Off label use, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 171 | 26499709 |
US |
||
Syringe issue, Drug dose omission by device, No adverse event, |
||||
RISPERIDONE, |
||||
| 172 | 26499890 |
US |
62 | |
Drug dose omission by device, Product container seal issue, Device leakage, Device breakage, Device issue, No adverse event, |
||||
RISPERIDONE, |
||||
| 173 | 26499949 |
US |
69 | 2 |
Headache, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 174 | 26500434 |
US |
46 | 2 |
Device difficult to use, Injection site pain, Device use error, Wrong technique in product usage process, Drug dose omission by device, Headache, Sinus disorder, |
||||
ERENUMAB-AOOE, |
||||
| 175 | 26500622 |
DO |
9 | 2 |
Drug dose omission by device, Device malfunction, |
||||
SOMATROPIN, |
||||
| 176 | 26501014 |
US |
79 | 2 |
Cataract, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 177 | 26501261 |
US |
||
Dyspnoea, Illness, Drug dose omission by device, Device mechanical issue, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 178 | 26501348 |
US |
10 | 1 |
Drug dose omission by device, Device power source issue, Device delivery system issue, Device leakage, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 179 | 26501361 |
KR |
15 | 2 |
Drug dose omission by device, Device power source issue, |
||||
SOMATROPIN, |
||||
| 180 | 26501368 |
CO |
1 | |
Device mechanical issue, Device issue, Device breakage, Drug dose omission by device, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 181 | 26501710 |
IN |
||
Dementia, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 182 | 26501805 |
US |
||
Off label use, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, LEFLUNOMIDE, |
||||
| 183 | 26501807 |
US |
||
Drug dose omission by device, Device delivery system issue, Device malfunction, Product with quality issue administered, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 184 | 26501812 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 185 | 26502213 |
US |
16 | 1 |
Drug dose omission by device, Device breakage, |
||||
SOMATROPIN, |
||||
| 186 | 26502673 |
US |
1 | |
Drug dose omission by device, Device leakage, Product use issue, |
||||
SECUKINUMAB, EMPAGLIFLOZIN, |
||||
| 187 | 26502739 |
US |
80 | 2 |
Injection site bruising, Device difficult to use, Device use error, Accidental exposure to product, Drug dose omission by device, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 188 | 26497577 |
US |
18 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 189 | 26497582 |
US |
78 | |
Dyspnoea, Device issue, Wrong technique in product usage process, Drug dose omission by device, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, LISINOPRIL, OXYBUTYNIN, CHLORTHALIDONE, |
||||
| 190 | 26497583 |
US |
||
Device delivery system issue, Drug dose omission by device, Device malfunction, Wrong technique in device usage process, Wrong technique in product usage process, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 191 | 26497593 |
CA |
66 | |
Adrenal gland cancer, Uterine neoplasm, Device malfunction, Drug dose omission by device, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 192 | 26497622 |
US |
59 | 1 |
Device difficult to use, Drug dose omission by device, Accidental exposure to product, Exposure via skin contact, |
||||
ETANERCEPT, |
||||
| 193 | 26496913 |
US |
66 | 2 |
Blood cholesterol increased, Incorrect disposal of product, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 194 | 26497207 |
US |
61 | |
Drug dose omission by device, Device leakage, No adverse event, |
||||
PREDNISOLONE ACETATE, |
||||
| 195 | 26491987 |
US |
||
Drug dose omission by device, Device delivery system issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 196 | 26491994 |
US |
||
Drug dose omission by device, Off label use, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 197 | 26491995 |
US |
||
Drug dose omission by device, Device delivery system issue, Product delivery mechanism issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 198 | 26491997 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 199 | 26491998 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 200 | 26492178 |
US |
65 | 2 |
Injection site pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28